• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宫颈癌诊治后的第二原发癌。

Second Primary Cancer after Diagnosis and Treatment of Cervical Cancer.

机构信息

Gynecologic Cancer Branch, National Cancer Center, Goyang, Korea.

Center for Uterine Cancer, National Cancer Center, Goyang, Korea.

出版信息

Cancer Res Treat. 2016 Apr;48(2):641-9. doi: 10.4143/crt.2014.326. Epub 2015 Jul 17.

DOI:10.4143/crt.2014.326
PMID:26194366
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4843727/
Abstract

PURPOSE

This study was conducted to investigate the incidence and survival outcomes of second primary cancers after the diagnosis of cervical cancer.

MATERIALS AND METHODS

Data from the Korea Central Cancer Registry between 1993 and 2010 were reviewed and analyzed. Standardized incidence ratios (SIRs) of second primary cancers among women with cervical cancer were analyzed. Kaplan-Meier survival curves were constructed for cervical cancer patients with or without a second primary cancer.

RESULTS

Among 72,805 women with cervical cancer, 2,678 (3.68%) developed a second primary cancer within a mean follow-up period of 7.34 years. The overall SIR for a second cancer was 1.08 (95% confidence interval, 1.04 to 1.12). The most frequent sites of second primary cancers were the vagina, bone and joints, vulva, anus, bladder, lung and bronchus, corpus uteri, and esophagus. However, the incidence rates of four second primary cancers (breast, rectum, liver, and brain) were decreased. The 5-year and 10-year overall survival rates were 78.3% and 72.7% in all women with cervical cancer, and for women with a second primary cancer, these rates were 83.2% and 65.5% from the onset of cervical cancer and 54.9% and 46.7% from the onset of the second primary cancer, respectively.

CONCLUSION

The incidence rates of second primary cancers were increased in women with cervical cancer compared to the general population, with the exception of four decreasing cancers. The 10-year overall survival rates were decreased in cervical cancer patients with a second primary cancer.

摘要

目的

本研究旨在探讨宫颈癌诊断后第二原发癌的发病率和生存结局。

材料和方法

回顾性分析了 1993 年至 2010 年期间韩国中央癌症登记处的数据。分析了宫颈癌女性第二原发癌的标准化发病比(SIR)。为患有或不患有第二原发癌的宫颈癌患者构建了 Kaplan-Meier 生存曲线。

结果

在 72805 名宫颈癌女性中,2678 名(3.68%)在平均 7.34 年的随访期内发生了第二原发癌。总体而言,第二癌症的 SIR 为 1.08(95%置信区间,1.04 至 1.12)。第二原发癌最常见的部位是阴道、骨和关节、外阴、肛门、膀胱、肺和支气管、子宫体和食管。然而,四种第二原发癌(乳房、直肠、肝脏和大脑)的发病率降低。所有宫颈癌女性的 5 年和 10 年总生存率分别为 78.3%和 72.7%,而患有第二原发癌的女性,这两个比率分别为从宫颈癌发病开始的 83.2%和 65.5%,以及从第二原发癌发病开始的 54.9%和 46.7%。

结论

与普通人群相比,宫颈癌女性的第二原发癌发病率增加,除了四种发病率降低的癌症。患有第二原发癌的宫颈癌患者的 10 年总生存率降低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ce4/4843727/2140c8211dfa/crt-2014-326f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ce4/4843727/e48e787140f8/crt-2014-326f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ce4/4843727/db6b69f45c5d/crt-2014-326f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ce4/4843727/2140c8211dfa/crt-2014-326f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ce4/4843727/e48e787140f8/crt-2014-326f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ce4/4843727/db6b69f45c5d/crt-2014-326f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ce4/4843727/2140c8211dfa/crt-2014-326f3.jpg

相似文献

1
Second Primary Cancer after Diagnosis and Treatment of Cervical Cancer.宫颈癌诊治后的第二原发癌。
Cancer Res Treat. 2016 Apr;48(2):641-9. doi: 10.4143/crt.2014.326. Epub 2015 Jul 17.
2
Risk of second primary malignancies in women with cervical cancer: a population-based study in Taiwan over a 30-year period.宫颈癌女性的二次原发恶性肿瘤风险:台湾 30 年期间的基于人群研究。
Gynecol Oncol. 2012 Dec;127(3):625-30. doi: 10.1016/j.ygyno.2012.09.004. Epub 2012 Sep 10.
3
Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk.104760例宫颈癌幸存者中的二次癌症:长期风险评估
J Natl Cancer Inst. 2007 Nov 7;99(21):1634-43. doi: 10.1093/jnci/djm201. Epub 2007 Oct 30.
4
Italian cancer figures, report 2013: Multiple tumours.《2013年意大利癌症数据报告:多发性肿瘤》
Epidemiol Prev. 2013 Jul-Oct;37(4-5 Suppl 1):1-152.
5
Cumulative risk of second primary cancers in women with index primary cancers of uterine cervix and incidence of lower anogenital tract cancers, Michigan, 1985-1992.1985 - 1992年密歇根州子宫颈原发性癌症女性患者发生第二原发性癌症的累积风险及下肛门生殖道癌症的发病率
Gynecol Oncol. 1997 Feb;64(2):213-23. doi: 10.1006/gyno.1996.4551.
6
Second primary cancers after cervical intraepithelial neoplasia III and invasive cervical cancer in Southeast England.英格兰东南部宫颈上皮内瘤变III级和浸润性宫颈癌后的第二原发性癌症
Gynecol Oncol. 2003 Jul;90(1):131-6. doi: 10.1016/s0090-8258(03)00231-2.
7
Metachronous Second Primary Malignancies after Head and Neck Cancer in a Korean Cohort (1993-2010).韩国队列(1993 - 2010年)中头颈部癌后异时性第二原发性恶性肿瘤
PLoS One. 2015 Jul 28;10(7):e0134160. doi: 10.1371/journal.pone.0134160. eCollection 2015.
8
Pelvic inflammatory disease increases the risk of a second primary malignancy in patients with cervical cancer treated by surgery alone.盆腔炎会增加仅接受手术治疗的宫颈癌患者发生第二种原发性恶性肿瘤的风险。
Medicine (Baltimore). 2016 Nov;95(47):e5409. doi: 10.1097/MD.0000000000005409.
9
Risk of Second Primary Cancer among Prostate Cancer Patients in Korea: A Population-Based Cohort Study.韩国前列腺癌患者发生第二原发性癌症的风险:一项基于人群的队列研究。
PLoS One. 2015 Oct 15;10(10):e0140693. doi: 10.1371/journal.pone.0140693. eCollection 2015.
10
Second primary cancers in patients with carcinoma in situ of the uterine cervix. The Norwegian experience 1970-1992.子宫颈原位癌患者的第二原发性癌症。挪威1970 - 1992年的经验
Int J Cancer. 1995 Jul 4;62(1):29-33. doi: 10.1002/ijc.2910620108.

引用本文的文献

1
Association between radiation therapy for primary endometrial cancer and risk of second primary malignancies: a retrospective cohort study.原发性子宫内膜癌放疗与第二原发恶性肿瘤风险的关联:一项回顾性队列研究。
Sci Rep. 2024 Oct 19;14(1):24623. doi: 10.1038/s41598-024-74840-4.
2
Increased risk of subsequent primary lung cancer among female hormone-related cancer patients: A meta-analysis based on over four million cases.女性激素相关癌症患者后续原发性肺癌风险增加:基于超过 400 万例病例的荟萃分析。
Chin Med J (Engl). 2024 Aug 5;137(15):1790-1801. doi: 10.1097/CM9.0000000000003132. Epub 2024 Jul 8.
3
The risk for subsequent primary lung cancer after cervical carcinoma: A quantitative analysis based on 864,627 cases.

本文引用的文献

1
Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010.韩国 1999-2010 年宫颈癌、子宫内膜癌和卵巢癌的发病率。
J Gynecol Oncol. 2013 Oct;24(4):298-302. doi: 10.3802/jgo.2013.24.4.298. Epub 2013 Oct 2.
2
Health behaviors of cancer survivors: the Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV, 2007-09).癌症幸存者的健康行为:第四次韩国国家健康和营养检查调查(KNHANES IV,2007-09)。
Jpn J Clin Oncol. 2013 Oct;43(10):981-7. doi: 10.1093/jjco/hyt118. Epub 2013 Aug 23.
3
Racial disparities in cervical cancer survival over time.
宫颈癌后发生原发性肺癌的风险:基于 864627 例病例的定量分析。
PLoS One. 2024 Jun 24;19(6):e0305670. doi: 10.1371/journal.pone.0305670. eCollection 2024.
4
Differences of characteristics, influencing factors, and treatment effects on the survival in patients with first and second primary cervical cancer.首发性和第二原发性宫颈癌患者的特征、影响因素及生存治疗效果的差异。
Prev Med Rep. 2023 Nov 10;36:102504. doi: 10.1016/j.pmedr.2023.102504. eCollection 2023 Dec.
5
Nomograms constructed for predicting diagnosis and prognosis in cervical cancer patients with second primary malignancies: a SEER database analysis.用于预测伴有第二原发性恶性肿瘤的宫颈癌患者诊断和预后的列线图:一项监测、流行病学和最终结果(SEER)数据库分析
J Cancer Res Clin Oncol. 2023 Nov;149(14):13201-13210. doi: 10.1007/s00432-023-05192-1. Epub 2023 Jul 21.
6
Second Malignancies Following Primary Cervical Cancer Diagnosis: Analysis of the SEER Database.原发性宫颈癌诊断后的二次恶性肿瘤:监测、流行病学和最终结果(SEER)数据库分析
Cureus. 2022 Jun 21;14(6):e26171. doi: 10.7759/cureus.26171. eCollection 2022 Jun.
7
Second primary malignancies in cervical cancer and endometrial cancer survivors: a population-based analysis.宫颈癌和子宫内膜癌幸存者的第二原发恶性肿瘤:基于人群的分析。
Aging (Albany NY). 2022 May 4;14(9):3836-3855. doi: 10.18632/aging.204047.
8
MicroRNAs expression analysis shows key affirmation of Synaptopodin-2 as a novel prognostic and therapeutic biomarker for colorectal and cervical cancers.微小RNA表达分析显示,突触足蛋白-2作为结直肠癌和宫颈癌一种新的预后及治疗生物标志物得到了关键确认。
Heliyon. 2021 Jun 19;7(6):e07347. doi: 10.1016/j.heliyon.2021.e07347. eCollection 2021 Jun.
9
Survival analysis of second primary malignancies after cervical cancer using a competing risk model: implications for prevention and surveillance.使用竞争风险模型对宫颈癌后第二原发性恶性肿瘤进行生存分析:对预防和监测的意义
Ann Transl Med. 2021 Feb;9(3):239. doi: 10.21037/atm-20-2003.
10
Ultrasound-Targeted Microbubble Destruction Enhances the Inhibitive Efficacy of miR-21 Silencing in HeLa Cells.超声靶向破坏微泡增强 miR-21 沉默对 HeLa 细胞的抑制作用。
Med Sci Monit. 2021 Feb 19;27:e923660. doi: 10.12659/MSM.923660.
宫颈癌生存率的时间变化中的种族差异。
Cancer. 2013 Oct 15;119(20):3644-52. doi: 10.1002/cncr.28261. Epub 2013 Jul 31.
4
Radiation dose and subsequent risk for stomach cancer in long-term survivors of cervical cancer.宫颈癌长期生存者的辐射剂量与胃癌风险。
Int J Radiat Oncol Biol Phys. 2013 Aug 1;86(5):922-9. doi: 10.1016/j.ijrobp.2013.04.010. Epub 2013 May 22.
5
Prediction of cancer incidence and mortality in Korea, 2013.2013 年韩国癌症发病率与死亡率预测。
Cancer Res Treat. 2013 Mar;45(1):15-21. doi: 10.4143/crt.2013.45.1.15. Epub 2013 Mar 31.
6
Human hepatocyte carcinogenesis (review).人肝癌发生(综述)。
Int J Oncol. 2013 Apr;42(4):1133-8. doi: 10.3892/ijo.2013.1829. Epub 2013 Feb 19.
7
A prospective observational study with dose volume parameters predicting rectosigmoidoscopic findings and late rectosigmoid bleeding in patients with uterine cervical cancer treated by definitive radiotherapy.一项前瞻性观察研究,使用剂量体积参数预测接受根治性放疗的宫颈癌患者的直肠乙状结肠镜检查结果和晚期直肠乙状结肠出血。
Radiat Oncol. 2013 Jan 31;8:28. doi: 10.1186/1748-717X-8-28.
8
Cancer statistics, 2013.癌症统计数据,2013 年。
CA Cancer J Clin. 2013 Jan;63(1):11-30. doi: 10.3322/caac.21166. Epub 2013 Jan 17.
9
Quality of life in long-term cervical cancer survivors: a population-based study.长期宫颈癌幸存者的生活质量:一项基于人群的研究。
Gynecol Oncol. 2013 Apr;129(1):222-8. doi: 10.1016/j.ygyno.2012.12.033. Epub 2012 Dec 30.
10
Global burden of human papillomavirus and related diseases.人乳头瘤病毒及相关疾病全球负担。
Vaccine. 2012 Nov 20;30 Suppl 5:F12-23. doi: 10.1016/j.vaccine.2012.07.055.